Women's Representation in Leadership Positions in Academic Medical Oncology, Radiation Oncology, and Surgical Oncology Programs.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
02 03 2020
Historique:
entrez: 12 3 2020
pubmed: 12 3 2020
medline: 9 9 2020
Statut: epublish

Résumé

Women are underrepresented in medical leadership positions; however, representation of women among academic oncology leadership is unknown. To evaluate representation of women overall and in leadership positions in academic medical oncology (MO), radiation oncology (RO), and surgical oncology (SO) programs and to examine the association of women leadership with overall faculty representation of women per program. In this cross-sectional study, MO, RO, and SO training program websites were queried from October 2018 through June 2019. All faculty from 265 of 273 accredited MO, RO, and SO training programs (97.1%) were included. Gender. Observed proportions of women in leadership positions compared with the expected proportion of overall women faculty in MO, RO, and SO were assessed. Rates of representation of women across each MO, RO, and SO program's faculty based on the presence or absence of a woman in a leadership position were compared. Of 6030 total faculty, only 2164 (35.9%) were women. Total representation of women among MO, RO, and SO faculty was 37.1% (1563 of 4215), 30.7% (389 of 1269), and 38.8% (212 of 546), respectively. Women composed only 21.7% (30 of 138), 11.7% (11 of 94), and 3.8% (1 of 26) of MO, RO, and SO chair positions, respectively. The observed proportion of women in chair positions was significantly lower than the expected proportion for MO, RO, and SO. In all, 47.9%, 33%, and 18.5% of MO, RO, and SO programs, respectively, had at least 1 woman in a leadership position (program director or chair). Programs with 1 or more women in a leadership position were associated with a higher mean (SD) percentage of women faculty than those without at least 1 woman leader in MO (40.7% [12.5%] vs 33.1% [11.0%]; P < .001) and RO (36.2% [13.3%] vs 23.4% [12.3%]; P < .001) but not SO (40.2% [15.4%] vs 31.4% [16.9%]; P = .29). Gender disparity exists in academic MO, RO, and SO faculty, which is magnified at the chair level. Programs in MO and RO with a woman physician in a leadership position were associated with a higher percentage of women faculty, but this was not true for SO. These data will serve as a benchmark to monitor progress toward a more balanced workforce.

Identifiants

pubmed: 32159809
pii: 2762630
doi: 10.1001/jamanetworkopen.2020.0708
pmc: PMC7066474
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e200708

Commentaires et corrections

Type : CommentIn

Références

Lancet. 2019 Feb 9;393(10171):594-600
pubmed: 30739695
Cureus. 2019 May 9;11(5):e4628
pubmed: 31312554
Plast Reconstr Surg. 2019 Oct;144(4):1001-1009
pubmed: 31568320
N Engl J Med. 2006 Jul 20;355(3):281-7
pubmed: 16855268
Laryngoscope. 2019 Sep 18;:
pubmed: 31532847
Lancet Oncol. 2019 Mar;20(3):327-329
pubmed: 30745089
N Engl J Med. 2014 Oct 16;371(16):1471-4
pubmed: 25317867
J Oncol Pract. 2014 Sep;10(5):e328-34
pubmed: 25052501
Lancet. 2019 Feb 9;393(10171):560-569
pubmed: 30739691
J Womens Health (Larchmt). 2019 Feb;28(2):225-232
pubmed: 30596542
Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):31-33
pubmed: 28587049
JAMA Intern Med. 2019 Mar 1;179(3):433-435
pubmed: 30615072
Int J Radiat Oncol Biol Phys. 2016 Jul 1;95(3):1009-1016
pubmed: 27105719

Auteurs

Mudit Chowdhary (M)

Department of Radiation Oncology, Rush University Medical Center, Chicago, Illinois.

Akansha Chowdhary (A)

Robert H. Lurie Comprehensive Cancer Center, Division of Hematology and Medical Oncology, Northwestern University, Chicago, Illinois.

Trevor J Royce (TJ)

Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill.

Kirtesh R Patel (KR)

Department of Radiation Oncology, Kaiser Permanente, Atlanta, Georgia.

Arpit M Chhabra (AM)

Department of Radiation Oncology, New York Proton Center, New York.

Shikha Jain (S)

Division of Hematology, Oncology and Stem Cell Transplant, Rush University Medical Center, Chicago, Illinois.

Miriam A Knoll (MA)

John Theurer Cancer Center, Department of Radiation Oncology, Hackensack University Medical Center, Hackensack, New Jersey.

Neha Vapiwala (N)

Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia.

Barbara Pro (B)

Robert H. Lurie Comprehensive Cancer Center, Division of Hematology and Medical Oncology, Northwestern University, Chicago, Illinois.

Gaurav Marwaha (G)

Department of Radiation Oncology, Rush University Medical Center, Chicago, Illinois.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH